Lessons Learned about the Need for Early Screening for Depression during the First Months of the COVID-19 Pandemic in the United States.
Issues Ment Health Nurs
; 43(3): 272-281, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-1409755
ABSTRACT
A nationwide survey assessed the prevalence and pandemic-related risk factors of major depressive disorder (MDD) at the initial onset of the COVID-19 pandemic. Findings showed a significant increase in the prevalence of MDD (22.7%) compared to the pre-pandemic 12-month estimate (10.4%). Specific pandemic-related concerns, along with significant increases in stress, loneliness, fatigue, and substance use behaviors are noted for those with the provisional diagnosis of MDD. Early screening and detection for potential MDD cases can reduce the severity and duration of maladaptive symptoms, decreasing the risk for future depression episodes and the potential loss of quality of life and productivity.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Depressive Disorder, Major
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Issues Ment Health Nurs
Year:
2022
Document Type:
Article
Affiliation country:
01612840.2021.1975333
Similar
MEDLINE
...
LILACS
LIS